SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-790742
Filing Date
2016-12-12
Accepted
2016-12-12 16:13:59
Documents
19
Period of Report
2016-12-12
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d307789d8k.htm 8-K 22894
2 EX-99.1 d307789dex991.htm EX-99.1 16142
3 EX-99.2 d307789dex992.htm EX-99.2 22534
4 GRAPHIC g307789ex99_1s10g1.jpg GRAPHIC 201616
5 GRAPHIC g307789ex99_1s11g1.jpg GRAPHIC 195638
6 GRAPHIC g307789ex99_1s12g1.jpg GRAPHIC 187444
7 GRAPHIC g307789ex99_1s13g1.jpg GRAPHIC 178165
8 GRAPHIC g307789ex99_1s14g1.jpg GRAPHIC 257521
9 GRAPHIC g307789ex99_1s15g1.jpg GRAPHIC 310178
10 GRAPHIC g307789ex99_1s1g1.jpg GRAPHIC 151804
11 GRAPHIC g307789ex99_1s2g1.jpg GRAPHIC 378437
12 GRAPHIC g307789ex99_1s3g1.jpg GRAPHIC 315143
13 GRAPHIC g307789ex99_1s4g1.jpg GRAPHIC 200145
14 GRAPHIC g307789ex99_1s5g1.jpg GRAPHIC 227116
15 GRAPHIC g307789ex99_1s6g1.jpg GRAPHIC 281753
16 GRAPHIC g307789ex99_1s7g1.jpg GRAPHIC 158335
17 GRAPHIC g307789ex99_1s8g1.jpg GRAPHIC 191138
18 GRAPHIC g307789ex99_1s9g1.jpg GRAPHIC 173291
19 GRAPHIC g307789g1213021355748.jpg GRAPHIC 4124
  Complete submission text file 0001193125-16-790742.txt   4763828
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36297 | Film No.: 162046428
SIC: 2834 Pharmaceutical Preparations